Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
J Dermatol. 2019 Jan;46(1):e1-e18. doi: 10.1111/1346-8138.14604. Epub 2018 Dec 18.
Although rheumatologists, neurologists and dermatologists see patients with polymyositis (PM) and dermatomyositis (DM), their management appears to vary depending on the physician's specialty. The aim of the present study was to establish the treatment consensus among specialists of the three fields to standardize the patient care. We formed a research team supported by a grant from the Ministry of Health, Labor and Welfare, Japan. Clinical questions (CQ) on the management of PM and DM were raised. A published work search on CQ was performed primarily using PubMed. Using the nominal group technique, qualified studies and results in the published work were evaluated and discussed to reach consensus recommendations. They were sent out to the Japan College of Rheumatology, Japanese Society of Neurology and Japanese Dermatological Association for their approval. We reached a consensus in 23 CQ and made recommendations and a decision tree for management was proposed. They were officially approved by the three scientific societies. In conclusion, a multidisciplinary treatment consensus for the management of PM and DM was established for the first time.
尽管风湿科医生、神经科医生和皮肤科医生都会接诊多发性肌炎（PM）和皮肌炎（DM）患者，但他们的治疗方法似乎因医生的专业领域而异。本研究的目的是在这三个领域的专家之间建立治疗共识，以规范患者的治疗。我们成立了一个由日本厚生劳动省资助的研究团队。针对 PM 和 DM 的管理提出了临床问题（CQ）。主要使用 PubMed 对 CQ 的已发表文献进行了搜索。利用名义群体技术，对已发表文献中的合格研究和结果进行了评估和讨论，以达成共识建议。这些建议被发送给日本风湿病学会、日本神经病学会和日本皮肤科协会征求他们的意见。我们在 23 个 CQ 中达成了共识，并提出了管理建议和决策树。这些建议最终被这三个科学协会正式批准。总之，首次为 PM 和 DM 的管理制定了多学科治疗共识。
